BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 236 filers reported holding BEAM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,500 | -24.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $319,300 | +4.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $306,200 | -69.1% | 10,000 | +30.0% | 0.00% | -50.0% |
| Q2 2021 | $990,000 | -76.8% | 7,692 | -85.6% | 0.00% | -75.0% |
| Q1 2021 | $4,273,000 | -49.0% | 53,388 | -48.0% | 0.01% | -52.9% |
| Q4 2020 | $8,377,000 | +1602.6% | 102,606 | +484.5% | 0.02% | +1600.0% |
| Q2 2020 | $492,000 | – | 17,554 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |